큐리오시스

494120· KOSDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

₩11,030+8.24%

2026-08-04

Financials

Valuation Metrics

큐리오시스's Market Cap is ₩842B. Ranked #1357 of 2,436 in KR market (top 56%), #753 of 1,649 on KOSDAQ (top 46%), #148 of 234 in Pharmaceuticals, Biotechnology & Life Sciences (top 63%) by Market Cap.

Investment Metrics(as of 2026-08-04)

Metric	Value	Rank
Size
Market Cap	84.16B KRW	KR#1,357/2,436 Sec#148/234
Revenue	6.91B KRW	KR#2,323/2,436 Sec#187/234
Net Income	-7.14B KRW	KR—/2,436 Sec—/234
Total Assets	32.81B KRW	KR#2,310/2,436 Sec#219/234
Net Assets	26.73B KRW	KR#2,196/2,436 Sec#201/234
Value
P/B	3.15x	KR#2,132/2,436 Sec#168/234
P/S	12.18x	KR#2,293/2,436 Sec#167/234
FCF Yield	-11.39%	KR—/2,436 Sec—/234
Profitability
ROE	-26.73%	KR#2,136/2,436 Sec#170/234
ROA	-21.77%	KR#2,244/2,436 Sec#181/234
Op. Margin	-105.60%	KR#2,312/2,436 Sec#175/234
Revenue Growth	-25.46%	KR#2,120/2,436 Sec#193/234
Financial Health
Debt Ratio	122.76%	KR#719/2,436 Sec#88/234
Total Debt	2.77B KRW	KR#1,870/2,436 Sec#180/234
FCF	-9.58B KRW	KR#1,701/2,436 Sec#145/234
Cash	21.36B KRW	KR#1,203/2,436 Sec#88/234
Current Ratio	8.14x	KR#139/2,436 Sec#34/234
Performance
1M Return	-11.08%	KR#1,827/2,436 Sec#184/234
From 52W High	-77.12%	KR#2,314/2,436 Sec#215/234
1Y MDD	-80.71%	KR#2,311/2,436 Sec#217/234
Trading
Volume	117,820 shares	KR#844/2,436 Sec#83/234
Foreign Own.	3.92%	KR—/2,436 Sec—/234
Per Share
EPS	-520 KRW	KR—/2,436 Sec—/234
BPS	1,754 KRW	KR#2,097/2,436 Sec#176/234